AAAAAA

   
Results: 1-11 |
Results: 11
IL-6 upregulates its own receptor on some human myeloma cell lines
Authors: Thabard, W Collette, M Mellerin, MP Puthier, D Barille, S Bataille, R Amiot, M
Citation: W. Thabard et al., IL-6 upregulates its own receptor on some human myeloma cell lines, CYTOKINE, 14(6), 2001, pp. 352-356
Myeloma cells induce imbalance in the osteoprotegerin/osteoprotegerin ligand system in the human bone marrow environment
Authors: Giuliani, N Bataille, R Mancini, C Lazzaretti, M Barille, S
Citation: N. Giuliani et al., Myeloma cells induce imbalance in the osteoprotegerin/osteoprotegerin ligand system in the human bone marrow environment, BLOOD, 98(13), 2001, pp. 3527-3533
The role of interleukin-6 and interleukin-6/interleukin-6 receptor-alpha complex in the pathogenesis of multiple myeloma
Authors: Barille, S Bataille, R Amiot, M
Citation: S. Barille et al., The role of interleukin-6 and interleukin-6/interleukin-6 receptor-alpha complex in the pathogenesis of multiple myeloma, EUR CYTOKIN, 11(4), 2000, pp. 546-551
Soluble IL-6R alpha upregulates IL-6, MMP-1 and MMP-2 secretion in bone marrow stromal cells
Authors: Barille, S Collette, M Thabard, W Bleunven, C Bataille, R Amiot, M
Citation: S. Barille et al., Soluble IL-6R alpha upregulates IL-6, MMP-1 and MMP-2 secretion in bone marrow stromal cells, CYTOKINE, 12(9), 2000, pp. 1426-1429
Myeloma cells release soluble interleukin-6R alpha in relation to disease progression by two distinct mechanisms: Alternative splicing and proteolytic cleavage
Authors: Thabard, W Barille, S Collette, M Harousseau, JL Rapp, MJ Bataille, R Amiot, M
Citation: W. Thabard et al., Myeloma cells release soluble interleukin-6R alpha in relation to disease progression by two distinct mechanisms: Alternative splicing and proteolytic cleavage, CLIN CANC R, 5(10), 1999, pp. 2693-2697
Differential expression of Bcl-2 in human plasma cell disorders according to proliferation status and malignancy
Authors: Puthier, D Pellat-Deceunynck, C Barille, S Robillard, N Rapp, MJ Juge-Morineau, N Harousseau, JL Bataille, R Amiot, M
Citation: D. Puthier et al., Differential expression of Bcl-2 in human plasma cell disorders according to proliferation status and malignancy, LEUKEMIA, 13(2), 1999, pp. 289-294
Zoledronate is a potent inhibitor of myeloma cell growth and secretion of IL-6 and MMP-1 by the tumoral environment
Authors: Derenne, S Amiot, M Barille, S Collette, M Robillard, N Berthaud, P Harousseau, JL Bataille, R
Citation: S. Derenne et al., Zoledronate is a potent inhibitor of myeloma cell growth and secretion of IL-6 and MMP-1 by the tumoral environment, J BONE MIN, 14(12), 1999, pp. 2048-2056
Production of metalloproteinase-7 (matrilysin) by human myeloma cells and its potential involvement in metalloproteinase-2 activation
Authors: Barille, S Bataille, R Rapp, MJ Harousseau, JL Amiot, M
Citation: S. Barille et al., Production of metalloproteinase-7 (matrilysin) by human myeloma cells and its potential involvement in metalloproteinase-2 activation, J IMMUNOL, 163(10), 1999, pp. 5723-5728
Mcl-1 and Bcl-x(L) are co-regulated by IL-6 in human myeloma cells
Authors: Puthier, D Derenne, S Barille, S Moreau, P Harousseau, JL Bataille, R Amiot, M
Citation: D. Puthier et al., Mcl-1 and Bcl-x(L) are co-regulated by IL-6 in human myeloma cells, BR J HAEM, 107(2), 1999, pp. 392-395
CD130 rather than CD126 expression is associated with disease activity in multiple myeloma
Authors: Barille, S Thabard, W Robillard, N Moreau, P Pineau, D Harousseau, JL Bataille, R Amiot, M
Citation: S. Barille et al., CD130 rather than CD126 expression is associated with disease activity in multiple myeloma, BR J HAEM, 106(2), 1999, pp. 532-535
The absence of CD56 (NCAM) on malignant plasma cells is a hallmark of plasma cell leukemia and of a special subset of multiple myeloma
Authors: Pellat-Deceunynck, C Barille, S Jego, G Puthier, D Robillard, N Pineau, D Rapp, MJ Harousseau, JL Amiot, M Bataille, R
Citation: C. Pellat-deceunynck et al., The absence of CD56 (NCAM) on malignant plasma cells is a hallmark of plasma cell leukemia and of a special subset of multiple myeloma, LEUKEMIA, 12(12), 1998, pp. 1977-1982
Risultati: 1-11 |